Cargando…
A systematic scoping review of faropenem and other oral penems: treatment of Enterobacterales infections, development of resistance and cross-resistance to carbapenems
BACKGROUND: Antimicrobial resistance is an urgent global healthcare concern. Beyond carbapenems as broad-spectrum, often ‘last resort’ antibiotics, oral penem antibiotics currently are approved only in Japan and India, used for the treatment of indications including urinary tract infections (UTIs)....
Autores principales: | Gandra, Sumanth, Takahashi, Satoshi, Mitrani-Gold, Fanny S, Mulgirigama, Aruni, Ferrinho, Diogo A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777757/ https://www.ncbi.nlm.nih.gov/pubmed/36570688 http://dx.doi.org/10.1093/jacamr/dlac125 |
Ejemplares similares
-
2447. Ertapenem and Faropenem for the Treatment of Drug-Resistant Tuberculosis
por: Satta, Giovanni, et al.
Publicado: (2018) -
1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020) -
2225. Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022) -
2226. Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022) -
187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)